Maintenance of blood flow rate on dialysis with self-centering CentrosFLO catheter: A multicenter prospective study

Anil K Agarwal1, Stephen R Ash2, 3

  • 1Professor of Medicine, Chief, Section of Nephrology at University Hospiital East, Director, Interventional Nephrology, Director of Clinical Scholarship for FAME, The Ohio State University Wexner Medical Center, Columbus, Ohio, 43210, USA.

Hemodialysis International. International Symposium on Home Hemodialysis
|June 28, 2016
PubMed

Insights

The CentrosFLO central venous catheter (CVC) maintained high blood flow rates over 26 weeks in dialysis patients. This novel catheter design significantly reduces fibrous sheathing, improving long-term dialysis CVC patency.

Area of Science:

  • Nephrology
  • Vascular Access
  • Medical Device Engineering

Background:

  • Chronic central venous catheters (CVCs) used for dialysis often experience reduced patency and blood flow due to fibrous sheathing at the lumen tips.
  • This degradation impacts the efficacy and longevity of dialysis vascular access.

Purpose of the Study:

  • To evaluate the long-term patency and blood flow performance of the novel CentrosFLO central venous catheter in dialysis patients.
  • To assess if the unique catheter tip design mitigates fibrous sheathing and maintains hydraulic resistance.

Main Methods:

  • A prospective, multicenter, observational study involving 75 dialysis patients using the CentrosFLO catheter via internal jugular veins.
  • Data on blood flow rate and pressures were collected for up to 26 weeks.
  • Kaplan-Meier analysis was used to assess patency and flow rates.

Main Results:

  • 87% of patients maintained a blood flow rate above 300 mL/min for the entire 26-week follow-up period.
  • No decline in average dialysis blood flow rate was observed.
  • Hydraulic resistance of the catheter lumens remained stable, indicating no significant fibrous sheathing.

Conclusions:

  • The CentrosFLO catheter demonstrates sustained long-term patency and effective blood flow rates in dialysis patients.
  • The catheter's design appears to successfully prevent fibrous sheathing, offering a significant clinical improvement over existing CVCs.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.8K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.4K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.6K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.7K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
329
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.3K